The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases

Tobacco Cessation Clinical Trial

Official title:

Investigation of the Effectiveness of Immediate Smoking Cessation Interventions During Routine Outpatient Service in Current Smoker Chronic Airway Disease Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05764343
• Other study ID #: EKGG
• Status: Completed
• Phase: N/A
• Start date: November 15, 2022
• Est. completion date: September 15, 2023

Study information

• Verified date: November 2023
• Source: Recep Tayyip Erdogan University Training and Research Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Smoking cessation support is provided by smoking cessation outpatient clinics in our country. Smokers with chronic airway diseases can also apply to these services by making an appointment from quit lines. Quit rates of that group patients were found to be similar to the general population. In novel smoking cessation support approaches immediate cessation support is reported to be more effective than routine practice. The sample in these studies consists of individuals who applied for lung health screening programmes. There is no study in the literature examining the effect of this immediate support on patients with chronic airway diseases' quit success. Our aim with this study is to examine impact of immediate cessation support by getting an appointment to the same cessation clinic instantly on our sample's cessation success.

Description:

Patients who are current smokers (who have smoked at least 100 cigarettes in their lifetime and still smoke daily or some days) will be randomized in a 1:1 ratio to the two arms in sequential order of presentation, after they have been identified and given written informed consent about the study. Demographic and clinical features will be filled. A brief smoking cessation intervention will be applied to one group and they will be recommended to apply to smoking cessation outpatient clinics by obtaining appointment from quit lines, as the way of current routine practice. Those randomized to the other group will have an immediate appointment at the smoking cessation outpatient clinic in addition to the brief smoking cessation intervention. Both patient groups will be called after 1 week by phone to inquire about their smoking cessation status and their application to smoking cessation outpatient clinics. Both groups will be called again in the 3rd month and their smoking cessation status, their application to smoking cessation outpatient clinics, and the duration/status of using pharmacological smoking cessation treatments will be questioned.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 397
• Est. completion date: September 15, 2023
• Est. primary completion date: June 15, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Being age 18 years and over,

2. Having diagnoses of asthma and/or COPD and/or bronchiectasis for at least 6 months,

3. Applying to the chest diseases outpatient clinics,

4. Being an current smoker,

5. Those who agree to participate in the study,

6. Patients who can be reached by phone calls at 1 week and 3 months after randomization.

Exclusion Criteria:

1. Those with active psychiatric disorders

2. Patients with impaired cognitive functions.

Related Conditions & MeSH terms

• Asthma COPD
• Bronchiectasis
• Bronchiectasis Adult
• Pulmonary Disease, Chronic Obstructive
• Tobacco Cessation

Intervention

Other:
• Immediate smoking cessation support
Smoker patients with chronic airway diseases (asthma and/or COPD and/or bronchiectasis) will be evaluated for the inclusion criteria. Afterwards they will be randomized as routine support arm (as the current procedure of the care) and immediate support arm (intensive brief cessation advices following by the immediate arrangement of the appointment from the same clinic's smoking cessation service). Both arms will be followed remotely at first week and third months of the randomization regarding their quit status as well as their use of evidence based cessation treatments.

Locations

Country	Name	City	State
Turkey	Recep Tayyip Erdogan University, Training and Research Hospital	Rize

Sponsors (2)

Lead Sponsor	Collaborator
Recep Tayyip Erdogan University Training and Research Hospital	Turkish Thoracic Society

Country where clinical trial is conducted

Turkey, 

References & Publications (4)

Buttery SC, Williams P, Mweseli R, Philip KEJ, Sadaka A, Bartlett EJ, Devaraj A, Kemp S, Addis J, Derbyshire J, Chen M, Morris K, Laverty A, Hopkinson NS. Immediate smoking cessation support versus usual care in smokers attending a targeted lung health ch — View Citation

Jimenez-Ruiz CA, Andreas S, Lewis KE, Tonnesen P, van Schayck CP, Hajek P, Tonstad S, Dautzenberg B, Fletcher M, Masefield S, Powell P, Hering T, Nardini S, Tonia T, Gratziou C. Statement on smoking cessation in COPD and other pulmonary diseases and in sm — View Citation

Karadogan D, Onal O, Kanbay Y. How does reimbursement status affect smoking cessation interventions? A real-life experience from the Eastern Black Sea region of Turkey. Tob Induc Dis. 2019 Jan 22;17:05. doi: 10.18332/tid/100412. eCollection 2019. Erratum — View Citation

Williams PJ, Philip KEJ, Gill NK, Flannery D, Buttery S, Bartlett EC, Devaraj A, Kemp SV, Addis J, Derbyshire J, Chen M, Morris K, Laverty AA, Hopkinson NS. Immediate, Remote Smoking Cessation Intervention in Participants Undergoing a Targeted Lung Health — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quit rate of both study arms	To compare the quit rate at third month of randomization in the both arms: intensive support arm compared to routine support arm. A quitter will be considered who have never smoked since the target quit day.	At third month of randomization
Secondary	Smoking cessation outpatient clinic application rate of both study arms	The admission status to smoking cessation outpatient clinics of both arms will be evaluated: admitted at least once or never admitted.	At third month